Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-24 · accession 0000028823-23-000166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-26 | 2023-12-24 | DBD | PEARLMAN EMANUEL R | Dir | A - Grant | $0.00 | +40.0K | 42.0K | +2,000% | $0 |
| D | 2023-12-26 | 2023-12-24 | DBD | PEARLMAN EMANUEL R | Dir | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-24 | A | A | 40,000 | $0.00 | 42,000 | D | — | — | |
| 2 | Derivative | Director Stock Option (right to buy) | 2023-12-24 | A | A | 80,000 | $0.00 | 80,000 | D | $30.00 · — to 2028-12-24 | 80,000 Common Stock | (F1) Granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended; option is generally exercisable in substantially equal installments on each of the first four anniversaries of September 22, 2023. |